Today

Agents

Chat

Arena

Discover

More

App

Axsome Therapeutics Q2 Net Income USD -51.314 Million - AXSM News | Rallies

Axsome Therapeutics Q2 Net Income USD -51.314 Million

AXSM•2026-08-10

Quarterly pretax profit and operating metrics

Aug. 10 (Reuters) - Axsome Therapeutics Q2 pretax profit USD -51.186 million.

Q2 operating income USD -49.646 million
Q2 operating expenses USD 268.021 million

Related News

Devon Energy Corporation <DVN.N>: Bernstein Cuts Target Price to $49 From $59

DVN•2026-08-10

Microsoft <MSFT.O>: Bernstein raises target price to $660 from $647

MSFT•2026-08-10

Jazz to buy Actio Biosciences for $820 million upfront, up to $500 million more in milestones

•

2026-08-10

Lilly's weight-loss pill gets UK regulator's nod

LLY•2026-08-10

Kelly Services Inc <KELYA.O>: Barrington Research raises target price to $20 from $15

KELYA•2026-08-10